I sure hope not. Associating genetic variations with symptoms or physiological findings is a relatively clear-cut statistical problem. The major challenge in whole genome association studies (or their extension to whole genome sequencing data) is to get enough data to draw meaningful conclusions.

There is a cognitive dissonance in biology/medicine: On the one hand they complain about too much data to process, but at publication time, the power is too low...